Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy

Aberrant activation of mTORC1 in cardiomyocytes was associated with myocardial fibrosis and a trend for worse prognosis in patients with NICM, indicating that persistently activated mTORC1 contributes to progression of human heart failure.